Sign Up to like & get
recommendations!
0
Published in 2021 at "AntiCancer Research"
DOI: 10.21873/anticanres.14882
Abstract: Background/Aim: Sorafenib, an oral multi-kinase inhibitor, has been shown to improve the outcome of patients with osteosarcoma (OS). However, the anti-OS effect and mechanism of sorafenib has not yet been fully understood. The main purpose…
read more here.
Keywords:
apoptotic metastatic;
anti apoptotic;
sorafenib;
metastatic potential ... See more keywords